1,464
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

, , , , , , , , , , , , & show all
Article: e1149667 | Received 11 Nov 2015, Accepted 27 Jan 2016, Published online: 29 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qun Zhang, Zhou Ding, Li Wan, Wenyu Tong, Jialei Mao, Li Li, Jing Hu, Mi Yang, Baorui Liu & Xiaoping Qian. (2020) Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer. Cancer Biology & Therapy 21:2, pages 157-169.
Read now

Articles from other publishers (8)

Shashi Anand, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, Amod Sharma, Srijan Acharya, Mohammad Aslam Khan, Seema Singh & Ajay Pratap Singh. (2023) From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies. Cancer and Metastasis Reviews.
Crossref
Jun Yuan, Jiarui Li, Ce Gao, Chun Jiang, Ze Xiang & Jian Wu. (2022) Immunotherapies catering to the unmet medical need of cold colorectal cancer. Frontiers in Immunology 13.
Crossref
Li Chen, Xiaoying Jiang, Yuanheng Li, Qiqi Zhang, Qing Li, Xiaoyan Zhang, Meng Zhang, Qiongfang Yu & Dian Gao. (2022) How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Clinical Immunology 237, pages 108962.
Crossref
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek, Filip Trčka, Jan Verner, Stanislav Drápela, Radek Fedr, Tereza Suchánková, Barbora Pavlatovská, Eva Ondroušková, Irena Kubelková, Danica Zapletalová, Štěpán Tuček, Peter Múdry, Dagmar Adámková Krákorová, Lucia Knopfová, Jan Šmarda, Karel Souček, Lubor Borsig & Petr Beneš. (2022) Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clinical & Experimental Metastasis 39:2, pages 375-390.
Crossref
Li Liang, Mengling Liu, Xun Sun, Yitao Yuan, Ke Peng, Khalid Rashid, Yiyi Yu, Yuehong Cui, Yanjie Chen & Tianshu Liu. (2021) Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer. Cancer Cell International 21:1.
Crossref
Onat Kadioglu, Mohamed Saeed, Nuha Mahmoud, Shaymaa Azawi, Kristin Mrasek, Thomas Liehr & Thomas Efferth. (2021) Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion. Archives of Toxicology 95:3, pages 959-974.
Crossref
Binfan Chen, Ang Gao, Bin Tu, Yonghui Wang, Xiaolu Yu, Yingshu Wang, Yanfeng Xiu, Bing Wang, Yakun Wan & Yongzhuo Huang. (2020) Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery. Biomaterials 255, pages 120187.
Crossref
Toan Pham, Sandra Carpinteri, Shienny Sampurno, Lloyd Pereira, Sara Roth, Vignesh Narasimhan, Phillip Darcy, Jayesh Desai, Alexander G. Heriot & Robert G. Ramsay. (2019) Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model. Journal of Gastrointestinal Surgery 23:3, pages 626-633.
Crossref